Edgewise Therapeutics Inc
NASDAQ:EWTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Edgewise Therapeutics Inc
NASDAQ:EWTX
|
US |
|
D
|
Droneacharya Aerial Innovations Ltd
BSE:543713
|
IN |
|
Oriental Land Co Ltd
F:OLL
|
JP |
|
P
|
Protean eGov Technologies Ltd
BSE:544021
|
IN |
|
Schrole Group Ltd
ASX:SCL
|
AU |
|
M
|
Maison Solutions Inc
NASDAQ:MSS
|
US |
|
Octaware Technologies Ltd
BSE:540416
|
IN |
|
Thomson Medical Group Ltd
SGX:A50
|
SG |
|
Element Fleet Management Corp
TSX:EFN
|
CA |
|
Commcenter SA
MAD:CMM
|
ES |
|
MTAR Technologies Ltd
NSE:MTARTECH
|
IN |
|
H
|
Harmony Gold Mining Company Ltd
JSE:HAR
|
ZA |
|
Ortel Communications Ltd
NSE:ORTEL
|
IN |
|
Flamingo AI Ltd
ASX:FGO
|
AU |
|
Kodal Minerals PLC
LSE:KOD
|
UK |
|
S
|
Sino Splendid Holdings Ltd
HKEX:8006
|
HK |
|
Best Mart 360 Holdings Ltd
HKEX:2360
|
HK |
|
E
|
Everbridge Inc
F:2E7
|
US |
Profitability Summary
Edgewise Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
Edgewise Therapeutics Inc
Margins Comparison
Edgewise Therapeutics Inc Competitors
| Country | Company | Market Cap |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|
| US |
|
Edgewise Therapeutics Inc
NASDAQ:EWTX
|
3.5B USD |
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Edgewise Therapeutics Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US |
|
Edgewise Therapeutics Inc
NASDAQ:EWTX
|
3.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
